{"id":48703,"date":"2022-09-22T16:02:26","date_gmt":"2022-09-22T14:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/"},"modified":"2022-09-22T16:02:26","modified_gmt":"2022-09-22T14:02:26","slug":"paige-and-optrascan-partner-to-streamline-digital-pathology-adoption","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/","title":{"rendered":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Paige<\/a>, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN<\/a>\u00ae, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The companies aim to reduce barriers to digitizing glass pathology slides, which will in turn enhance workflows in pathology and oncology.\n<\/p>\n

<\/a><\/p>\n

\nTogether, the companies will integrate Paige\u2019s clinical AI applications<\/a> and interoperable enterprise imaging platform with OptraSCAN\u2019s digital pathology scanner to offer advanced end-to-end digital pathology workflow solutions. This provides a streamlined path for pathologists to adopt Paige\u2019s leading suite of digital pathology applications, including the FDA-cleared FullFocus\u00ae whole-slide image viewer and AI applications including Paige Prostate Suite and Paige Breast Suite alongside OptraSCAN\u2019s affordable digital pathology scanners. OptraSCAN devices have 15 to 480 slide loading capabilities that digitize the glass slides at 40x in less than one minute per slide with patented composite imaging offering.\n<\/p>\n

\n\u201cWe are excited to work with OptraSCAN to make it easier for labs and healthcare networks around the world to adopt digital pathology workflows,\u201d said Andy Moye, Ph.D., Chief Executive Officer at Paige. \u201cThis collaboration is an important step in our mission to unlock the full potential of AI in routine clinical use and provide healthcare professionals with precise insights to help patients get the most effective care.\u201d\n<\/p>\n

\nAbhi Gholap, Founder and CEO of OptraSCAN said, \u201cOptraSCAN\u2019s mission to enable pathology slide digitization at fractional costs is eventually resulting into higher market demand for digital pathology applications. This partnership with Paige will facilitate adoption of digital infrastructure for global clinical and molecular pathology community in an efficient way.\u201d\n<\/p>\n

\nAbout Paige
\n
<\/b>Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists\u2019 workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.\n<\/p>\n

\nFor additional information, please visit: https:\/\/www.Paige.ai<\/a>, Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

\nAbout OptraSCAN, Inc.
\n
<\/strong>OptraSCAN\u00ae are pioneers in the On-Demand Digital Pathology\u00ae System, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the barriers to \u201cGo Digital\u201d no matter the size of the pathology lab, the lab\u2019s throughput or global location.\n<\/p>\n

\nOptraSCAN\u2019s end-to-end digital pathology solution provides effective acquisition of whole slide images, viewing, storing, real-time sharing, reporting and AI & ML based Image analysis solutions via On-Demand or outright purchase model.\n<\/p>\n

\nPlease visit www.optrascan.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPaige Media:<\/b>
Jon Yu
\n
ICR Westwicke
\n
475.395.5375
\n
Jon.Yu@westwicke.com<\/a>\n<\/p>\n

\nOptraSCAN Media:<\/b>
Arnol Rios
\n
Director (Business Development)
\n
408.524.5300
\n
arnol@optraventures.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN\u00ae, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The companies aim to reduce barriers to digitizing glass … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48703","6":"format-standard","7":"category-industry"},"yoast_head":"\nPaige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN\u00ae, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The companies aim to reduce barriers to digitizing glass ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T14:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption\",\"datePublished\":\"2022-09-22T14:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/\"},\"wordCount\":534,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005130\\\/en\\\/1136000\\\/21\\\/paige-large-on-light-R.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/\",\"name\":\"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005130\\\/en\\\/1136000\\\/21\\\/paige-large-on-light-R.jpg\",\"datePublished\":\"2022-09-22T14:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005130\\\/en\\\/1136000\\\/21\\\/paige-large-on-light-R.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005130\\\/en\\\/1136000\\\/21\\\/paige-large-on-light-R.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/","og_locale":"en_US","og_type":"article","og_title":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN\u00ae, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of digital pathology technology in the United States, European Union countries and United Kingdom. The companies aim to reduce barriers to digitizing glass ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-22T14:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption","datePublished":"2022-09-22T14:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/"},"wordCount":534,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/","url":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/","name":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg","datePublished":"2022-09-22T14:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220922005130\/en\/1136000\/21\/paige-large-on-light-R.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/paige-and-optrascan-partner-to-streamline-digital-pathology-adoption\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Paige and OptraSCAN Partner to Streamline Digital Pathology Adoption"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48703"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48703\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}